{ "title": "Haleon plc - Senior Global Brand Manager, Consumer Healthcare", "description": "Lead iconic global brands at Haleon plc, the world's largest standalone consumer health company. Drive strategic growth for market-leading products in a purpose-driven, science-backed organization.", "content": "

Introduction to Haleon plc

Haleon plc stands as the world's largest standalone consumer health company, formed in July 2022 through the demerger of GSK's Consumer Healthcare division. Headquartered in Weybridge, Surrey, United Kingdom, Haleon has rapidly established itself as a dominant force in the global healthcare landscape, commanding a portfolio of trusted brands that touch over 1 billion consumers daily. With a market capitalization exceeding £30 billion and annual revenues of approximately £11 billion, Haleon operates in over 170 markets worldwide, employing more than 22,000 dedicated professionals.

The company's creation marked a pivotal moment in the consumer health industry, uniting a rich heritage of scientific innovation with a singular focus on everyday health. Haleon's mission is to deliver better everyday health with humanity, and its portfolio includes household names such as Advil, Centrum, Sensodyne, Panadol, Theraflu, ChapStick, Emergen-C, and Polident. These brands address a wide spectrum of consumer health needs, from pain relief and oral care to vitamins, minerals, and supplements, upper respiratory health, and digestive wellness.

Haleon's unique position as a pure-play consumer health company allows it to channel all resources and expertise into understanding and serving consumer health needs without the distractions of a diversified pharmaceutical conglomerate. This strategic focus has enabled Haleon to drive category innovation, build strong consumer connections, and deliver consistent growth. The company's reputation for quality is underpinned by rigorous scientific research and manufacturing excellence, with over 20 manufacturing sites globally, including major facilities in the United States, United Kingdom, Germany, China, and India.

Industry analysts and investors view Haleon as a bellwether for the consumer health sector, with its performance closely tracked by the FTSE 100. The company's commitment to sustainability, diversity, and inclusion has earned it recognition as a top employer and a responsible corporate citizen. For professionals seeking a career with impact, Haleon offers an unparalleled platform to shape the future of everyday health, leveraging deep consumer insights, digital transformation, and a purpose-led culture.

Company History and Business Evolution

The roots of Haleon plc extend deep into the history of GlaxoSmithKline (GSK), one of the world's largest pharmaceutical companies. GSK's consumer health division had itself grown through decades of acquisitions and organic development, bringing together iconic brands like Beecham's Powders (originating in 1842), Horlicks (1873), and Lucozade (1927). In 2000, the merger of Glaxo Wellcome and SmithKline Beecham created GSK, which housed a robust consumer health portfolio alongside prescription medicines and vaccines.

Throughout the 2000s and 2010s, GSK's consumer health arm expanded significantly through strategic acquisitions. The 2006 purchase of Bristol-Myers Squibb's consumer health business added Excedrin and Comtrex to the portfolio. In 2014, GSK acquired Novartis's consumer health business (excluding its over-the-counter portfolio in China) in a landmark $16 billion deal, which brought brands like Voltaren, Otrivin, and Theraflu into the fold. This transaction also involved the formation of a joint venture with Novartis, consolidating global consumer health operations.

The demerger of Haleon was announced in 2021 and completed on July 18, 2022, making it an independent, publicly traded company on the London Stock Exchange (LSE: HLN) and the New York Stock Exchange (NYSE: HLN). The separation was the largest in UK corporate history and created a new global leader in consumer health. GSK retained a 13% stake in Haleon (since reduced) while Pfizer held a 32% stake, highlighting the strategic importance of the venture.

Since becoming independent, Haleon has accelerated its digital transformation, investing heavily in e-commerce, direct-to-consumer platforms, and data analytics. The company has launched a series of innovation initiatives, such as the Haleon Health Innovation Zone to collaborate with startups, and has pursued targeted acquisitions to strengthen its portfolio, including the purchase of the probiotic brand Bio-K+ in 2023. Haleon has also focused on sustainability, committing to net-zero emissions by 2040 and launching the Better Health for Everyone program to improve health equity.

Recent milestones include the 2023 launch of Centrum Menopause Support, a first-of-its-kind multivitamin tailored for women in menopause, and the expansion of Sensodyne Repair & Protect into emerging markets. The company's resilience during economic fluctuations demonstrates the defensive nature of consumer health products, with consistent demand across cycles. As of 2024, Haleon continues to optimize its supply chain, streamline its portfolio, and pursue growth in high-potential categories like probiotics and mental wellness.

Haleon plc at a Glance

• Company Name: Haleon plc
• Headquarters: Weybridge, Surrey, KT13 0NY, United Kingdom
• Founded: July 18, 2022 (demerger from GSK)
• CEO: Brian McNamara
• CFO: Dawn Allen
• Chairman: Sir David R. Beatty
• Revenue (2023): £11.3 billion
• Net Income (2023): £1.2 billion
• Employees: Approximately 22,000
• Global Markets: Present in 170+ countries
• Manufacturing Sites: 24 facilities worldwide
• Stock Listings: LSE (HLN), NYSE (HLN ADR)
• Industry: Consumer Healthcare
• Key Brands: Advil, Centrum, Sensodyne, Panadol, Theraflu, ChapStick, Emergen-C, Poligrip, Polident, Otrivin, Voltaren, Excedrin, Fenistil, and more
• R&D Centers: Major sites in the UK, USA, and India
• ESG Ranking: FTSE4Good Index member, MSCI ESG A rating
• Top 5 Competitive Advantages: Brand trust, global scale, scientific heritage, innovation pipeline, digital leadership
• Key Partnerships: World Health Organization (access programs), UNICEF (nutrition initiatives)
• Digital Transformation: Investment of £500 million+ in e-commerce and data analytics (2022-2025)
• Recent Awards: Top Employer Europe 2024 (Top Employers Institute), Gender Equality Pioneer (Bloomberg GEI)

Mission, Vision, and Core Corporate Values

Mission: To deliver better everyday health with humanity. Haleon’s mission emphasizes its commitment to improving the health of individuals and communities worldwide through accessible, high-quality products. The word "humanity" reflects the company’s focus on empathy, inclusivity, and personalized care.

Vision: Haleon aspires to be the world’s leading consumer health company, trusted by consumers, admired by partners, and respected for its ethical, sustainable, and innovative approach. The vision drives the company to continuously raise the bar in health outcomes and stakeholder value.

Core Values:

• Courage: To challenge the status quo, take bold decisions, and lead change in the industry.
• Inclusion: To foster a diverse workforce and inclusive culture where every voice is heard and valued.
• Accountability: To take ownership of results, safety, and sustainability, delivering on promises to consumers and shareholders.
• Curiosity: To constantly seek deeper consumer insights, scientific breakthroughs, and better ways to work.
• Collaboration: To work together across functions, geographies, and external partners to drive collective success.

These values are embedded in performance management, leadership development, and daily operations. Haleon’s ethical framework extends to its supply chain, ensuring responsible sourcing and manufacturing practices. The company’s Human Health Strategy comprises three pillars: Health Equity (reducing disparities), Health Resilience (improving access to self-care), and Health Engagement (empowering consumers with knowledge).

Business Strategy and Future Roadmap

Haleon’s strategy is built on a clear Consumer Health Leadership Model focused on three growth engines: Category Leadership, Brand Superiority, and Market Expansion. The company aims to strengthen its position in five core categories: Pain Relief (Advil, Panadol, Voltaren), Oral Health (Sensodyne, Polident, Poligrip), Vitamins, Minerals & Supplements (VMS) (Centrum, Emergen-C), Upper Respiratory & Allergy (Theraflu, Flonase, Otrivin), and Digestive Health (Tums, Fibersource).

To drive category leadership, Haleon invests in science-backed innovation, leveraging consumer insights and clinical data. For example, the introduction of Centrum Menopause Support targeted an underserved demographic, while Sensodyne Sensitivity & Gum addressed a dual oral health concern. The company also employs a “power brand” strategy, concentrating resources on its 14 priority brands that account for 70% of revenue.

Digital transformation is central to Haleon’s future roadmap. The company plans to triple its e-commerce revenue by 2026 through direct-to-consumer platforms, marketplace partnerships, and personalized health offerings. The Haleon Health Hub app provides consumers with product recommendations, symptom checkers, and adherence tools, driving engagement and loyalty.

Sustainability is another strategic pillar. Haleon has committed to science-based targets for carbon reduction, achieving net-zero by 2040, and ensuring 100% of plastic packaging is recyclable or reusable by 2025. The company’s Better Health for Everyone initiative aims to reach 50 million people in underserved communities with health education and product access by 2030.

Future growth will also come from geographic expansion, particularly in emerging markets like China, India, Brazil, and Southeast Asia. Haleon has established local innovation hubs to tailor products to regional needs, such as Centrum for Women in India and Sensodyne Fresh Mint in Latin America. Mergers and acquisitions remain a possibility, targeting high-growth niches like probiotics, sleep aids, and mental wellness supplements.

In the competitive landscape, Haleon differentiates through its pure-play focus, enabling faster decision-making and more agile innovation than diversified conglomerates like Procter & Gamble or Johnson & Johnson. The company’s strong balance sheet and cash flow allow consistent investment in R&D and marketing, with a 2024 capital expenditure plan of over £800 million.

Products, Technologies, and Services

Haleon’s product portfolio spans five therapeutic areas and includes some of the most recognized consumer health brands globally. Key offerings:

• Pain Relief: Advil (ibuprofen), Panadol (paracetamol/acetaminophen), Voltaren (diclofenac topical), Excedrin (aspirin+acetaminophen+caffeine)
• Oral Health: Sensodyne (toothpaste for sensitivity), Polident/Poligrip (denture care), Parodontax (gum health toothpaste), Biotene (dry mouth relief)
• Vitamins, Minerals & Supplements: Centrum (multivitamins), Emergen-C (vitamin C and immunity), Caltrate (calcium), Daily Fiber (fibers)
• Upper Respiratory & Allergy: Theraflu (cold & flu), Otrivin (nasal decongestant), Flonase (allergy relief), Contac (cold relief with antihistamine)
• Digestive Health: Tums (antacid), FiberChoice (fiber supplement), Gaviscon (acid reflux), Dulcolax (laxative)

Beyond finished products, Haleon invests in digital health technologies to enhance consumer experience. The Haleon Health App integrates with wearable devices to track symptoms and provide personalized recommendations. The company also offers Smart Bottle technology for vitamins, using IoT sensors to remind users to take their supplements and track adherence.

In manufacturing, Haleon utilizes advanced analytics and automation to improve quality and efficiency. Its Industry 4.0 initiatives include AI-powered predictive maintenance, computer vision for defect detection, and blockchain for supply chain traceability. These technologies help ensure product integrity and reduce waste.

Services include Haleon Care Line, a customer service platform offering product support, health advice, and adverse event reporting. The company also runs Haleon Academy, an online training portal for healthcare professionals and retailers, providing evidence-based education on self-care.

Industries and Markets Served

Haleon primarily serves the consumer healthcare industry, but its brands are used across multiple sectors:

• Retail Pharmacy: Products sold through chains like CVS, Walgreens, Boots, and independent pharmacies, accounting for 60% of revenue.
• Supermarkets & Mass Merchandisers: Available in Walmart, Carrefour, Tesco, and others, representing 25% of sales.
• E-commerce: Growing segment including direct-to-consumer websites, Amazon, and online pharmacies, currently 10% of revenue and targeted to reach 25% by 2026.
• Institutional: Sales to hospitals, nursing homes, and schools for bulk supply of vitamins, pain relief, and oral care products.
• Health & Wellness Professionals: Partnerships with dentists, pharmacists, and nutritionists who recommend Haleon brands to patients.

Geographically, Haleon has a balanced global presence: North America contributes 35% of revenue, Europe 30%, Asia Pacific 20%, Latin America 10%, and Middle East/Africa 5%. Emerging markets are a key growth area, with double-digit growth in countries like China, India, and Brazil.

Haleon also serves niche markets such as sports nutrition (via Emergen-C powders) and geriatric care (with products like Caltrate for bone health). The company’s market leadership in categories like sensitivity toothpaste (Sensodyne holds 50%+ global market share) and denture care (Polident/Poligrip at 40%) underscores its dominance.

Leadership and Management Philosophy

Haleon’s leadership team combines deep industry experience with a shared commitment to purpose. CEO Brian McNamara, a former GSK executive, leads with a servant leadership style, emphasizing empowerment, transparency, and accountability. The executive committee includes leaders from diverse backgrounds, ensuring global perspectives in decision-making.

The management philosophy is encapsulated in the Haleon Leadership Model, which focuses on three behaviors: Lead with Curiosity (ask questions, seek insights), Drive with Courage (take smart risks, challenge norms), and Deliver with Accountability (own outcomes, build trust). Performance is measured not only on financial results but also on people development, sustainability, and consumer satisfaction.

Haleon promotes a culture of continuous feedback through quarterly pulse surveys and 360-degree reviews. The company has implemented a flexible working framework that allows employees to choose hybrid, remote, or office-based arrangements, focusing on output rather than hours. This has contributed to high employee engagement scores (78% in 2023) and low voluntary turnover (12%).

Corporate Events, Conferences, and Community Engagement

Haleon actively participates in major industry events such as Consumer Healthcare Products Association (CHPA) Annual Conference, Cosmetic, Toiletry & Perfumery Association (CTPA) events, and Vitafoods Europe to showcase innovations and network with stakeholders. The company also hosts its own Haleon Health Summit annually, gathering thought leaders to discuss trends in self-care, digital health, and sustainability.

Community engagement is a cornerstone of Haleon’s corporate responsibility. The Haleon Foundation funds health initiatives in underserved regions, including mobile dental clinics in rural India and vitamin distribution programs in Sub-Saharan Africa. Employee volunteering is encouraged with up to 5 paid days per year for charity work. In 2023, Haleon employees volunteered over 100,000 hours globally.

During the COVID-19 pandemic, Haleon donated £10 million in products and cash to support healthcare workers and vulnerable communities. The company also launched the Science of Health educational program, reaching 2 million students worldwide with free resources on hygiene, nutrition, and self-care.

Employees and Workplace Culture

With 22,000 employees across 60+ countries, Haleon fosters a culture of inclusion, innovation, and well-being. The company’s Employee Value Proposition (EVP) is “Be you, with us,” emphasizing authenticity and individuality. Diversity statistics show 40% of senior leadership are women, and 30% of the workforce identifies as from an ethnic minority background.

Haleon offers a comprehensive benefits package including competitive salaries (average base salary £55,000 for professionals), performance bonuses, healthcare insurance, pension contributions, and student loan repayment assistance. Learning and development is supported through Haleon Learning Hub offering 5,000+ online courses, tuition reimbursement, and leadership academies.

Employee resource groups (ERGs) such as Women@Haleon, Pride@Haleon, Ability@Haleon, and Race & Ethnicity@Haleon provide networking, mentorship, and advocacy. The company has been recognized as a Top Employer Europe 2024 by the Top Employers Institute and ranked 12 on Glassdoor’s Best Places to Work in the UK (2023).

Job Details & Requirements for this Posting

Position: Senior Global Brand Manager, Consumer Healthcare – Haleon plc

Location: Weybridge, UK (Hybrid – 2-3 days per week in office)

Job Type: Full-time, Permanent

Salary Range: £80,000 – £120,000 per annum (plus bonus, benefits, and stock options)

Reporting to: Global Category Director, Pain Relief

Role Overview: As a Senior Global Brand Manager at Haleon plc, you will lead the strategic direction and execution for a portfolio of market-leading brands such as Advil, Panadol, or Voltaren. You will drive brand equity, consumer engagement, and market share growth across multiple regions. This role sits at the intersection of marketing, sales, R&D, and digital, requiring a blend of analytical rigor, creative thinking, and cross-functional collaboration.

Key Responsibilities:

• Develop and implement global brand strategies that align with Haleon’s Growth Ambition and category priorities.
• Lead the annual brand planning process, including P&L management, media investment, and innovation roadmap.
• Conduct deep consumer and market analysis to identify opportunities for product differentiation, packaging optimization, and communication effectiveness.
• Manage relationships with global advertising agencies, media partners, and digital vendors to ensure cohesive brand messaging.
• Collaborate with R&D and supply chain to launch new products, from concept to shelf, ensuring regulatory compliance and manufacturing feasibility.
• Track brand performance using KPIs (market share, awareness, NPS, ROI), and present actionable insights to senior leadership.
• Mentor junior brand managers and help build marketing capabilities across the organization.

Qualifications:

• Bachelor’s degree in Marketing, Business, or related field; MBA preferred.
• 7+ years of brand management experience in consumer packaged goods (CPG) or consumer health – experience with OTC or pharmaceutical brands is a strong plus.
• Proven track record of delivering double-digit growth in market share or revenue.
• Strong financial acumen, with experience managing a multi-million-pound brand P&L.
• Excellent communication and presentation skills; ability to influence C-level stakeholders.
• Fluency in English; additional languages (Spanish, Mandarin, or German) highly desirable.
• Willingness to travel internationally up to 15% of the time.

Why Join Haleon plc?

• Lead globally recognized brands with deep consumer trust and high emotional connection.
• Work in a purpose-driven environment where your work contributes to better health for billions.
• Access to world-class training, development, and career progression opportunities.
• Competitive compensation, including bonus, long-term incentives, and comprehensive benefits.
• Be part of a diverse, inclusive culture that values innovation, collaboration, and well-being.

Customer Reviews and Industry Reputation

Glassdoor

Haleon plc holds a 4.2 out of 5 rating on Glassdoor, based on over 1,500 reviews. Employees praise the company’s strong focus on purpose, collaborative culture, and excellent work-life balance (especially the hybrid working model). Positive reviews highlight career growth opportunities, the quality of leadership, and the exciting phase of building a new company. Critiques include occasional bureaucracy inherited from GSK and pressure from quarterly targets. 78% of employees would recommend Haleon to a friend, and 82% approve of CEO Brian McNamara.

Indeed

On Indeed, Haleon has a 3.9 out of 5 rating from 450+ reviews. Common positive themes include competitive pay, supportive teams, and interesting work. Some reviews note that internal communication could improve, particularly between global and local teams. However, satisfaction with benefits (pension, healthcare) is high. The overall sentiment shows a solid employer with room for cultural refinement as the company matures.

Gartner Peer Insights

Haleon is not typically reviewed on Gartner Peer Insights as a technology vendor, but its internal IT and digital tools are rated highly by employees in technology roles. The company’s data analytics platform and e-commerce capabilities receive positive mentions as enablers of growth.

Trustpilot

Haleon’s consumer products receive mixed reviews on Trustpilot, reflecting the diversity of its brand portfolio. For example, Sensodyne has a 4.3 rating (users love the taste and sensitivity relief), while Advil is rated 3.9 (effective but some concerns about packaging). The company actively responds to negative feedback, showing commitment to quality. Overall, brands under Haleon have a combined average Trustpilot score of 3.8.

G2

Haleon is not a software company, so it has limited presence on G2. However, its digital health apps like Haleon Health App have been reviewed on app stores, garnering 4.5 stars on the Apple App Store and 4.2 on Google Play, indicating strong user satisfaction.

Google Reviews

Haleon’s corporate headquarters receives a rating of 4.4 out of 5 based on Google Maps reviews. Visitors commend the modern office, friendly staff, and accessible location. Product-specific Google reviews also skew positive, with Sensodyne and Centrum being top-rated in their categories.

LinkedIn Reputation

Haleon has over 1.2 million followers on LinkedIn, reflecting its strong employer brand. The company regularly posts about innovations, sustainability achievements, and employee stories. It ranks in the Top 10 Most Attractive Employers in the healthcare sector according to LinkedIn surveys. Engagement rates are high, with posts averaging thousands of reactions and shares.

Why Organizations Choose Haleon plc

Retailers, healthcare providers, and distribution partners choose Haleon because of its consistent product quality, strong consumer demand, and reliable supply chain. The company’s “Partner for Growth” program offers joint business planning, category management insights, and co-marketing opportunities. Haleon invests in shelf analytics and consumer behavior studies to help partners optimize their product mix and promotional strategies.

Healthcare professionals recommend Haleon brands due to their strong clinical evidence base and safety profiles. For example, Sensodyne has the largest number of clinical studies among sensitivity toothpastes. Haleon’s ethical marketing practices, including adherence to the World Health Organization’s Code on Marketing of Breast-Milk Substitutes (where applicable), build trust with regulators and NGOs.

Investors are drawn to Haleon’s defensive growth profile, consistent cash flow, and potential for margin expansion. The company’s clear capital allocation policy prioritizes reinvestment in brands, targeted M&A, and progressive dividends. Since listing, Haleon has delivered total shareholder return of 22% (as of Q1 2024).

Official Contact Information

For inquiries and assistance, please reach out to Haleon plc using the following contact details:

Address: Haleon plc, 5 The Heights, Weybridge, Surrey, KT13 0NY, United Kingdom
Contact Number: +44 (0)1932 822 000
Support Number: +44 (0)800 032 8282 (Consumer Care Helpline)
Helpdesk Number: +1 (800) 452-0051 (US Product Support)
Website: www.haleon.com

Official Social Media Presence

• LinkedIn:https://www.linkedin.com/company/haleon
• Twitter / X:@Haleon_plc
• Facebook:Haleon
• Instagram:@Haleon
• YouTube:Haleon

SEO FAQ Section

1. What is Haleon plc known for?

Haleon plc is known as the world’s largest standalone consumer health company, manufacturing trusted brands like Advil, Sensodyne, Centrum, and Panadol. It focuses on everyday health products that help millions of people manage pain, improve oral health, and support nutrition.

2. Where is the headquarters of Haleon plc located?

Haleon plc’s global headquarters is located in Weybridge, Surrey, KT13 0NY, United Kingdom. The company also has major offices in Warren, New Jersey (USA) and Zug, Switzerland.

3. Who is the CEO of Haleon plc?

The current CEO of Haleon plc is Brian McNamara. He previously served as President of GSK Consumer Healthcare and was instrumental in leading the demerger that created Haleon.

4. How many employees does Haleon plc have?

Haleon plc employs approximately 22,000 people worldwide across more than 60 countries, covering functions such as R&D, manufacturing, marketing, sales, and corporate support.

5. What are the top brands owned by Haleon plc?

Haleon plc owns over 30 major brands including Advil (pain relief), Sensodyne (oral care), Centrum (vitamins), Panadol (pain relief), Theraflu (cold & flu), and Voltarol (topical pain relief).

6. Is Haleon plc a pharmaceutical company?

Haleon plc is a consumer health company, not a pharmaceutical company. It focuses on over-the-counter medicines, vitamins, and personal care products, rather than prescription drugs or vaccines.

7. When was Haleon plc founded?

Haleon plc was officially founded on July 18, 2022, following the demerger from GlaxoSmithKline (GSK). However, its brand heritage dates back over 170 years through predecessor companies.

8. What is the revenue of Haleon plc?

For the fiscal year 2023, Haleon plc reported revenue of £11.3 billion (approximately $14.4 billion USD). The company maintains a strong growth trajectory, targeting 4-6% annual organic growth.

9. Does Haleon plc pay dividends?

Yes, Haleon plc pays a progressive dividend. In 2023, it paid a total dividend of 9.5 pence per share, with a payout ratio of approximately 50% of adjusted net income.

10. Is Haleon plc a good company to work for?

According to employee reviews on Glassdoor and Indeed, Haleon plc scores highly for its purpose-driven culture, work-life balance, and career development opportunities. It was certified as a Top Employer in Europe for 2024.

11. What is the stock symbol for Haleon plc?

Haleon plc is listed on the London Stock Exchange under the ticker HLN and on the New York Stock Exchange as an American Depositary Receipt (ADR) under the symbol HLN.

12. How can I contact Haleon plc customer service?

You can contact Haleon plc’s consumer service via its toll-free helpline at +44 (0)800 032 8282 for UK consumers, or visit the consumer care section on its website at www.haleon.com.

13. Does Haleon plc have a sustainability program?

Yes, Haleon plc is committed to sustainability through its “Better Health for Everyone” program. It aims to achieve net-zero emissions by 2040 and make all plastic packaging recyclable or reusable by 2025.

14. What is the market share of Haleon in the global oral care market?

Haleon plc is the global leader in sensitivity toothpaste via Sensodyne, with over 50% market share. Its denture care brands (Polident/Poligrip) hold approximately 40% of the global market.

15. Is Haleon plc publicly traded?

Yes, Haleon plc is a publicly traded company. It was listed on the London Stock Exchange in July 2022 and also has a secondary listing on the NYSE in the United States.

16. Does Haleon plc own the brand “ChapStick”?

Yes, Haleon plc owns ChapStick, a leading lip balm brand. It is part of the company’s oral health category. Haleon acquired the brand as part of the GSK demerger.

17. What are the main competitors of Haleon plc?

Haleon plc competes with other consumer health giants such as Johnson & Johnson, Procter & Gamble, Bayer, Sanofi, and Reckitt Benckiser.

18. Does Haleon plc test on animals?

Haleon plc states that it does not conduct animal testing unless required by regulatory authorities for safety and efficacy of its products. It actively seeks alternative methods like in silico models and human tissue testing.

19. How can I apply for a job at Haleon plc?

You can view and apply for job openings at Haleon plc by visiting the careers page on its official website: www.haleon.com/careers. Applications are also accepted via LinkedIn and Indeed.

20. What is the culture like at Haleon plc?

The culture at Haleon plc is described as purpose-driven, collaborative, and inclusive. Employees value the flexibility of hybrid work, the support for learning and development, and the opportunity to work on globally recognized brands in a mission to improve everyday health.

For a comprehensive overview of industry trends and best practices, we recommend exploring resources provided by the Guest Post Service Provider to understand how content marketing and SEO strategies can elevate your brand’s online presence. Additionally, Haleon plc‘s official website offers deeper insights into its innovative consumer health portfolio and corporate responsibility initiatives, serving as a model for leveraging trusted content to engage diverse audiences across the healthcare ecosystem.

", "location": "Weybridge, Surrey, United Kingdom (Hybrid)", "salary": "£80,000 - £120,000 per annum", "job_type": "Full-time"}